Emmanuel Androulakis, Szymon Musiol, Michael Papadakis, Maria Teresa Tome Esteban
{"title":"Cardiac AL amyloidosis in a veteran endurance athlete with pre-existing apical hypertrophic cardiomyopathy: a case report.","authors":"Emmanuel Androulakis, Szymon Musiol, Michael Papadakis, Maria Teresa Tome Esteban","doi":"10.1093/ehjcr/ytaf443","DOIUrl":"10.1093/ehjcr/ytaf443","url":null,"abstract":"<p><strong>Background: </strong>Patients with mild phenotypes of chronic cardiomyopathies are often followed up over time, and there is a temptation to assume a change in symptom status or investigation results is due to the original pathology. The possibility of acquired pathology must be considered in these patients.</p><p><strong>Case summary: </strong>We present a case of a middle-aged veteran endurance athlete followed up for a mild phenotype of apical hypertrophic cardiomyopathy originally picked up due to an asymptomatic abnormal electrocardiogram (ECG). He developed subtle symptoms and morphological changes in his investigations (ECG, echocardiography, exercise tolerance test (ETT), and magnetic resonance imaging (MRI)). Due to the previously quiescent phenotype, a diagnosis of coexistent amyloid light-chain (AL) cardiac amyloidosis secondary to IgA lambda multiple myeloma was made.</p><p><strong>Discussion: </strong>This case underscores the importance of paying attention to subtle changes in symptoms and morphology when managing patients with mild phenotypes and athletes, and considering alternative pathology when these occur. Multimodality imaging is essential in the investigation of such patients.</p>","PeriodicalId":11910,"journal":{"name":"European Heart Journal: Case Reports","volume":"9 9","pages":"ytaf443"},"PeriodicalIF":0.8,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12477468/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145198710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Timothy Ryan, Laura Luttrell, Amit Shah, Kaitlyn Lam, Peter Dias, Aws Jasim, Andrew Laycock, Vimal Patel
{"title":"Long-term hydroxychloroquine use resulting in cardiomyopathy and conduction abnormalities: a case report.","authors":"Timothy Ryan, Laura Luttrell, Amit Shah, Kaitlyn Lam, Peter Dias, Aws Jasim, Andrew Laycock, Vimal Patel","doi":"10.1093/ehjcr/ytaf377","DOIUrl":"10.1093/ehjcr/ytaf377","url":null,"abstract":"<p><strong>Background: </strong>Diagnosing the cause of undifferentiated left ventricular hypertrophy (LVH) in a patient with progressive heart failure symptoms can present a diagnostic challenge, with potential for both inherited and acquired aetiologies. Hydroxychloroquine-induced cardiomyopathy (HCQ-CM) is a rare complication of long-term hydroxychloroquine use. This case report highlights its clinical presentation, key differential diagnoses, and treatment strategies.</p><p><strong>Case summary: </strong>A 56-year-old female with a longstanding history of systemic lupus erythematosus presented with progressive dyspnoea, fatigue, and fluid overload. Initial investigation revealed LVH with restrictive physiology, elevated cardiac biomarkers, and non-specific findings on echocardiography suggestive of an infiltrative cardiomyopathy. The diagnosis remained uncertain until an endomyocardial biopsy (EMB) confirmed HCQ-CM, characterized by the presence of curvilinear inclusion bodies. Following cessation of HCQ, there was a significant clinical improvement, with the patient achieving NYHA class I status at 6 months follow-up.</p><p><strong>Conclusion: </strong>This case highlights the critical importance of considering HCQ-CM, in the differential diagnosis of unexplained heart failure and LVH in patients on long-term HCQ therapy. A multi-parametric diagnostic approach-including EMB and genetic testing where appropriate-is essential to identify potentially reversible causes of cardiomyopathy and enable timely therapeutic adjustments.</p>","PeriodicalId":11910,"journal":{"name":"European Heart Journal: Case Reports","volume":"9 9","pages":"ytaf377"},"PeriodicalIF":0.8,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144999937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Imaging manifestations of a rare case: giant coronary artery aneurysm with thrombosis.","authors":"Lianze Du, Yao Yu, Qinghe Han","doi":"10.1093/ehjcr/ytaf439","DOIUrl":"10.1093/ehjcr/ytaf439","url":null,"abstract":"","PeriodicalId":11910,"journal":{"name":"European Heart Journal: Case Reports","volume":"9 9","pages":"ytaf439"},"PeriodicalIF":0.8,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12449201/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145112213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohammad Hamideh, Alec Rhodes, Aswin Srinivasan, Shudipan Chakraborty, Christopher Hawkins, Aakash Kumar, Hafez Golzarian
{"title":"Epinephrine and the paradox of Kounis syndrome: a case series and review of management.","authors":"Mohammad Hamideh, Alec Rhodes, Aswin Srinivasan, Shudipan Chakraborty, Christopher Hawkins, Aakash Kumar, Hafez Golzarian","doi":"10.1093/ehjcr/ytaf414","DOIUrl":"10.1093/ehjcr/ytaf414","url":null,"abstract":"<p><strong>Background: </strong>Epinephrine, the primary treatment for anaphylaxis, may paradoxically worsen underlying myocardial ischaemia due to its vasoconstrictive effects and potential to trigger vasospasm during an inflammatory response.</p><p><strong>Case summary: </strong>We present two cases of Kounis syndrome-one in a patient who developed Prinzmetal angina after exposure to shellfish and another who experienced cardiac arrest after receiving intramuscular epinephrine for an anaphylactic reaction to a wasp sting.</p><p><strong>Discussion: </strong>These cases emphasize the potential for anaphylaxis to precipitate acute coronary syndrome which can paradoxically be exacerbated by the routine administration of epinephrine in susceptible individuals, underscoring the importance of heightened vigilance and consideration of alternative therapies when Kounis syndrome is suspected.</p>","PeriodicalId":11910,"journal":{"name":"European Heart Journal: Case Reports","volume":"9 9","pages":"ytaf414"},"PeriodicalIF":0.8,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12449577/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145112215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Giulia La Vecchia, Ludovica Leo, Antonio Maria Leone, Rocco A Montone
{"title":"When chest pain is not what it seems: time for right diagnosis and right treatment-a case report.","authors":"Giulia La Vecchia, Ludovica Leo, Antonio Maria Leone, Rocco A Montone","doi":"10.1093/ehjcr/ytaf410","DOIUrl":"10.1093/ehjcr/ytaf410","url":null,"abstract":"<p><strong>Background: </strong>Chest pain is a common reason for emergency department (ED) visits, yet not all cases are attributable to coronary artery disease (CAD). The 2024 European Society of Cardiology (ESC) guidelines emphasize the importance of invasive coronary function testing in patients with angina and non-obstructive coronary arteries. Understanding alternative causes of chest pain is crucial for appropriate diagnosis and management.</p><p><strong>Case summary: </strong>A 58-year-old woman with hypertension, prediabetes, and a history of Takotsubo Syndrome presented with recurrent chest pain episodes, prompting multiple ED visits. Initial cardiac evaluations, including electrocardiogram (ECG), troponin levels, and ECG stress testing, were unremarkable. Repeated invasive coronary angiography (ICA) with a full physiological assessment ruled out obstructive CAD, microvascular dysfunction, and coronary vasospasm, suggesting a 'sensitive heart syndrome'. Further evaluation revealed a spinal schwannoma at the thoracic level, compressing the anterior spinal roots. Neuropathic chest pain was confirmed, and treatment with pregabalin led to symptom relief.</p><p><strong>Discussion: </strong>This case highlights the importance of a structured stepwise diagnostic approach to chest pain. When cardiac causes are excluded, alternative diagnoses such as neuropathic pain should be considered.</p>","PeriodicalId":11910,"journal":{"name":"European Heart Journal: Case Reports","volume":"9 9","pages":"ytaf410"},"PeriodicalIF":0.8,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405753/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144999942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Panayotis K Vlachakis, Eva Nyktari, George Oikonomou, Anastasios Apostolos, Skevos Sideris, Konstantinos Toutouzas, Costas Tsioufis, Maria Drakopoulou
{"title":"A multifaceted clinical portrait of Ebstein's anomaly: a case series.","authors":"Panayotis K Vlachakis, Eva Nyktari, George Oikonomou, Anastasios Apostolos, Skevos Sideris, Konstantinos Toutouzas, Costas Tsioufis, Maria Drakopoulou","doi":"10.1093/ehjcr/ytaf424","DOIUrl":"10.1093/ehjcr/ytaf424","url":null,"abstract":"<p><strong>Background: </strong>It was in 1866 when Wilhelm Ebstein first described a rare case of a 19-year-old cyanotic patient with tricuspid valve regurgitation caused by a congenital malformation. Since then, Ebstein's anomaly (EA) has been recognized as a condition that exhibits a diverse clinical course with a formidable challenge for clinicians in terms of diagnosis, management, and prognosis.</p><p><strong>Case summary: </strong>We present a case series of four patients with EA, shedding light on the varied clinical manifestations, treatment approaches, and outcomes that underscore the multifaceted nature of this condition.</p><p><strong>Discussion: </strong>The management of EA requires a comprehensive and individualized approach in specialized centres. The cardiologists responsible for the long-term care of these patients are faced with various challenging 'dilemmas' in the clinical course of the disease at different stages. The evolving landscape of cardiology offers a promising avenue for improving the outcomes and quality of life of patients with EA.</p>","PeriodicalId":11910,"journal":{"name":"European Heart Journal: Case Reports","volume":"9 9","pages":"ytaf424"},"PeriodicalIF":0.8,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12461249/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145184903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rescue percutaneous transluminal septal myocardial ablation for difficult ventilator weaning in drug-resistant hypertrophic obstructive cardiomyopathy: a case report.","authors":"Keisuke Nakabayashi, Takeshi Hayashi, Shota Kaiga, Nobuhito Kaneko, Minoru Shimizu","doi":"10.1093/ehjcr/ytaf435","DOIUrl":"10.1093/ehjcr/ytaf435","url":null,"abstract":"<p><strong>Background: </strong>Hypertrophic obstructive cardiomyopathy is a genetic cardiac disorder characterized by left ventricular outflow tract (LVOT) obstruction that can lead to haemodynamic instability. Managing preload in mechanically ventilated patients with hypertrophic obstructive cardiomyopathy is challenging because volume depletion exacerbates LVOT obstruction, whereas fluid overload induces pulmonary congestion. Weaning from mechanical ventilation (MV) in such cases requires precise volume management; however, conventional pharmacological therapy may be insufficient. Moreover, the role of percutaneous transluminal septal myocardial ablation (PTSMA) in the acute phase of symptomatic hypertrophic obstructive cardiomyopathy remains unclear.</p><p><strong>Case summary: </strong>A 51-year-old woman was admitted with cerebral haemorrhage and underwent emergency craniotomy. The patient experienced repeated episodes of acute heart failure, leading to several resuscitation attempts and requiring extended MV. Echocardiography revealed severe LVOT obstruction (peak LVOT pressure gradient, 119.7 mmHg). Attempts at volume optimization and pharmacological therapy failed to wean from MV or achieve haemodynamic stability. Given the patient's critical condition, rescue PTSMA was performed, which significantly reduced the LVOT gradient, thereby allowing aggressive volume reduction with haemodialysis and successful extubation within a week.</p><p><strong>Discussion: </strong>This case highlights the role of PTSMA as a rescue therapy for patients with hypertrophic obstructive cardiomyopathy experiencing difficulty weaning from MV and haemodynamic instability. Further studies are warranted to evaluate the safety, efficacy, and long-term outcomes of PTSMA as an acute-phase intervention in critically ill patients with hypertrophic obstructive cardiomyopathy.</p>","PeriodicalId":11910,"journal":{"name":"European Heart Journal: Case Reports","volume":"9 9","pages":"ytaf435"},"PeriodicalIF":0.8,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12448729/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145112147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mavacamten for treatment of symptomatic mid-ventricular obstruction in hypertrophic cardiomyopathy: a case report.","authors":"Samuel Hunziker, Philip Haaf, Annina S Vischer","doi":"10.1093/ehjcr/ytaf423","DOIUrl":"10.1093/ehjcr/ytaf423","url":null,"abstract":"","PeriodicalId":11910,"journal":{"name":"European Heart Journal: Case Reports","volume":"9 9","pages":"ytaf423"},"PeriodicalIF":0.8,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12448721/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145112184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}